Inventor
Jennifer R. Allen
Inventor
Newbury Park, CA, US
Overview
Patents· 45 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes9%
C07BGeneral methods of organic chemistry6%
C07CAcyclic or carbocyclic compounds6%
C07HSugars3%
C07KPeptides3%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
10,519,146KRAS G12C inhibitors and methods of using the same201910,246,429Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use20199,718,803'Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors'20179,611,261'Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use'20179,556,135'Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use'20179,550,762'Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use'20179,493,459'Azetidine and piperidine compounds useful as PDE10 inhibitors'20169,464,116'Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof'20169,376,450'Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors'20169,309,263'Fused multi-cyclic sulfone compounds as inhibitors of beta-secretase and methods of use thereof'20169,303,028'Azetidine and piperidine compounds useful as PDE10 inhibitors'20169,296,734'Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use'20169,174,992'Heterobicyclic compounds'20159,096,615'Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereof'20159,085,576'Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use'20158,957,073'Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors'20158,952,037'Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors'20158,946,230'Aryl- and heteroaryl- nitrogen-heterocyclic compounds as PDE10 inhibitors'20158,759,532'Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors'20148,691,986'Azetidine and piperidine compounds useful as PDE10 inhibitors'20148,637,500'Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors'20148,623,378'Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof'20148,497,265'Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors'20138,349,868'Azaquinolones that inhibit prolyl hydroxylase'20138,329,700'Pyrazine compounds as phosphodiesterase 10 inhibitors'20128,318,718'Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors'20128,247,418'Pyrazine compounds as phosphodiesterase 10 inhibitors'20128,097,620'Diazaquinolones that inhibit prolyl hydroxylase activity'20128,053,438'Pyrazine compounds as phosphodiesterase 10 inhibitors'20118,048,892'Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof'20118,048,894'Quinolones and azaquinolones that inhibit prolyl hydroxylase'20118,030,346'Heterocyclic quinolone derivatives that inhibit prolyl hydroxylase activity'20118,017,626'Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof'20118,012,968'Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof'20117,928,139'Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof'20117,879,335'Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof'20117,854,934'Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof'20107,728,130'Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity'20107,635,715'Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof'20097,595,339'CB1 modulator compounds'20097,569,726'Indanone derivatives that inhibit prolyl hydroxylase'20097,378,447'Muscarinic agonists'20087,326,731'Muscarinic agonists'20087,276,516'CB1 antagonist compounds'20077,265,246'Indane derivates as muscarinic receptor agonists'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007–2009Patents assigned to LILLY CO ELI (5)· patent assignee history
2007–2016Based in Indianapolis, IN, US· patent location history
2009–2019Patents assigned to AMGEN INC (36)· patent assignee history
2009–2019Based in Newbury Park, CA, US· patent location history
2012–2015Patents assigned to ALLEN JENNIFER R (11)· patent assignee history
2012–2015Patents assigned to RZASA ROBERT M (6)· patent assignee history
2012–2015Patents assigned to FROHN MICHAEL J (5)· patent assignee history
2019Based in Thousand Oaks, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 36 | 2009–2019 |
| ALLEN JENNIFER Rself | 11 | 2012–2015 |
| RZASA ROBERT M | 6 | 2012–2015 |
| FROHN MICHAEL J | 5 | 2012–2015 |
| LILLY CO ELI | 5 | 2007–2009 |
Locations
| Location | Patents | Span |
|---|---|---|
| Newbury Park, California, US | 35 | 2009–2019 |
| Indianapolis, IN, US | 9 | 2007–2016 |
| Thousand Oaks, California, US | 1 | 2019 |